ARTICLE | Clinical News
AeroVanc regulatory update
December 16, 2013 8:00 AM UTC
Savara said FDA granted Qualified Infectious Disease Product (QIDP) designation for AeroVanc to treat persistent methicillin-resistant Staphylococcus aureus (MRSA) lung infection in cystic fibrosis (C...